Company Filing History:
Years Active: 2025
Title: Uli Bialucha: Innovator in Antibody Therapeutics
Introduction
Uli Bialucha is a prominent inventor based in Winchester, MA (US), known for his contributions to the field of antibody therapeutics. With a focus on innovative solutions for treating disorders associated with CD161, Bialucha has made significant strides in medical research and development.
Latest Patents
Bialucha holds 2 patents, including his latest invention titled "Anti-CD161 antibodies and uses thereof." This invention relates to anti-CD161 antibodies, pharmaceutical compositions comprising such antibodies, and methods for using these antibodies to treat disorders associated with or mediated by CD161, such as certain cancers. Additionally, the invention encompasses expression vectors and host cells for producing these antibodies.
Career Highlights
Uli Bialucha is currently associated with Immunitas Therapeutics, Inc., where he continues to advance his research in antibody development. His work is pivotal in the ongoing quest for effective cancer treatments.
Collaborations
Bialucha collaborates with notable colleagues, including Alison Tisdale and George Punkosdy, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Uli Bialucha's work in the field of antibody therapeutics exemplifies the impact of innovative research on medical science. His patents and collaborations highlight his commitment to advancing treatment options for serious health conditions.